Aberrant activation of EGFR signaling is frequently associated with pathological conditions such as colorectal carcinoma, where it contributes significantly to tumor development and metastasis [29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,47,48,49,50,51]. This evidence concerns the gene EGFR and neoplasm.